Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Asian Biomedicine is Scopus-indexed (Q2, CiteScore 2), WoS SCIE. Published by Sciendo.
Checked against the index lists dated .
ISSN 1875-855XVerify ISSN ↗1905-7415Verify ISSN ↗
Publisher: Sciendo
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 259 / 669 | 61st | Q2 |
| Biochemistry, Genetics and Molecular Biology (all) | 144 / 223 | 35th | Q3 |
| Materials Science (miscellaneous) | 167 / 256 | 34th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 2.
Asian Biomedicine is Q2 in Medicine (all) (rank 259 of 669), Q3 in Biochemistry, Genetics and Molecular Biology (all) (rank 144 of 223) and Q3 in Materials Science (miscellaneous) (rank 167 of 256), by CiteScore 2025.
Asian Biomedicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2, which places it in quartile Q2 at the 61st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.340, quartile Q3, with an H-index of 25.
Asian Biomedicine is published by Sciendo. Its print ISSN is 1875-855X and its online ISSN is 1905-7415.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Asian Biomedicine has an h-index of 27 and a 2-year mean of 1.25 citations per paper (OpenAlex). Its Scopus CiteScore is 2, quartile Q2. On 2-year citations it ranks #223 of 646 Scopus journals in Medicine (all).
Asian Biomedicine published 38 papers in 2025; its busiest recent year was 2017 with 92. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 85 research articles (2023–2026), authors are most often from Thailand (34.5%), China (21.8%) and Türkiye (8.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.